Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MAZE compared with ERAS: revenue, margins and what each company keeps, and the suppliers and customers both name
MAZE
Maze Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
ERAS
Erasca, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
MAZE
Maze Therapeutics, Inc.
vs
ERAS
Erasca, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
MAZE, solid
ERAS, dashed
MAZE
Maze Therapeutics, Inc.
Change
31.42
· pre 31.10
· delayed
Mkt cap
$1.9B
Revenue
$20M
Q1 FY26
ERAS
Erasca, Inc.
Change
14.33
· pre 14.50
Pre-market
Sep 2 '83
Mkt cap
$5.0B
Revenue
—
vs
Compare
Pre-market
Sep 2 '83
MAZE
Maze Therapeutics, Inc.
vs
ERAS
Erasca, Inc.
31.42
pre 31.10
delayed
Price
14.33
pre 14.50
$1.9B
Mkt cap
$5.0B
Q1 FY26
$20M
Revenue
—
Change
Change
MAZE
31.42
vs
ERAS
14.33
Pre-market
Sep 2 '83